Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
Class II · Ongoing
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot: 24123460, Expires: October 31, 2027.
- Recalling firm
- Ascend Laboratories, LLC, Bedminster, NJ
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 15,696 x 30's bottles
- Distribution
- U.S.A. Nationwide
- Recall initiated
- May 5, 2026
- Classified
- June 2, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0556-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0556-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →